DIH Holdings US
DHAI
DHAI was delisted on the 6th of November, 2025.
0 hedge funds and large institutions have $0 invested in DIH Holdings US in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.
7.34% less ownership
Funds ownership: 7.34% → 0% (-7.3%)
100% less funds holding
Funds holding: 16 → 0 (-16)
100% less capital invested
Capital invested by funds: $718K → $0 (-$718K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$358K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$232K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$47.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$45.6K |
| 5 |
Citigroup
New York
|
-$9.44K |
DHAI Hedge Fund Activity: Q4 2025 in Review
0 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in DIH Holdings US (DHAI) for Q4 2025, worth a combined $0 — down 100% from $718K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of DHAI and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was OrbiMed, exiting entirely with an estimated $358K sold.
- 0 institutional investors held DIH Holdings US (DHAI) as of Q4 2025, down from 16 in Q3 2025.
- Funds reported $0 of DIH Holdings US stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new DIH Holdings US positions in Q4 2025 and 16 closed out, a net change of -16 holders.
- The largest DIH Holdings US seller in Q4 2025 was OrbiMed, an estimated $358K sold.
Based on aggregated 13F filings for Q4 2025.